Prior low-quality evidence has suggested that sodium bicarbonate may benefit critically ill patients with severe metabolic acidemia and acute kidney injury (AKI). In this randomized trial of patients ...

Please provide your email address to receive an email when new articles are posted on . Treating metabolic acidosis with sodium bicarbonate was associated with preserved kidney function and lower ...

In a randomized, placebo-controlled trial that enrolled patients with chronic kidney disease stages 3 and 4, sodium bicarbonate did not significant affect sit-to-stand time or bone mineral density.

Long Grove Pharmaceuticals is set to introduce Sodium Bicarbonate Injection. The product is commonly used in critical care settings yet routinely found on the drug shortages list, the company said.

BUDAPEST, Hungary — Sodium bicarbonate — long used, albeit sporadically, to correct metabolic acidosis in chronic kidney disease — is significantly better at slowing disease progression than standard ...

According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...

In 3 trials of sodium zirconium cyclosilicate, serum bicarbonate increased regardless of CKD stage. In addition to its potassium-binding ability, sodium zirconium cyclosilicate (SZC) may also increase ...

Cardiac surgery is one of the most common causes of acute kidney injury (AKI) worldwide. However, AKI is considered to be a potentially preventable complication of the procedure. “The ideal ...

Exela Pharma Sciences, LLC has voluntarily recalled 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton, due to a potential safety concern with vial breakage and ...